Cambridge, Cambridgeshire, United Kingdom In 2015 was created Fund Twenty8, which is appeared as VC. The company was established in Europe in United Kingdom. The main office of represented VC is situated in the Cambridge.
The real fund results show that this VC is 5 percentage points more often commits exit comparing to other companies. The average startup value when the investment from Fund Twenty8 is 5-10 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2017. Deals in the range of 1 - 5 millions dollars are the general things for fund.
The fund was created by Goncalo de Vasconcelos, James Sore, Tom Britton. We also calculated 2 valuable employees in our database.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Biotechnology, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Lightpoint Medical. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Fund Twenty8, startups are often financed by Venture Founders, Techstart Ventures, SBRI Healthcare. The meaningful sponsors for the fund in investment in the same round are Venture Founders, SyndicateRoom, Oxford Technology Management. In the next rounds fund is usually obtained by 24 Haymarket.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Baoying Fund | China, Futian, Guangdong |
| BC Tech Association | British Columbia, Canada, Vancouver |
| Bow River Capital Partners | Colorado, Denver, United States |
| C.Blair Asset Management | Connecticut, Cos Cob, United States |
| DS Polaris | - |
| EJ Funds | - |
| Infinity Group US | Bloomfield, Connecticut, United States |
| ING Capital LLC | New York, New York, United States |
| Inveready Technology Investment Group | Barcelona, Catalonia, Spain |
| Jiashi Tong Guang | Beijing, Beijing, China |
| JimiStore | China, Hangzhou, Zhejiang |
| Sandberg Development | - |
| Sandbox Industries | Chicago, Illinois, United States |
| Shenzhen Qianhai HuizhiTongbao Investment Fund | - |
| Superior Capital Partners | Detroit, Michigan, United States |
| TitletownTech | Green Bay, United States, Wisconsin |
| TriGem Computer | - |
| University of Toronto | Canada, Ontario, Toronto |
| UVET - American Express Travel | Italy, Lombardia, Milano |
| Xinchang Tiansheng Zhoucheng | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Liopa | $589K | 08 Apr 2019 | Belfast, Northern Ireland, United Kingdom | ||
SupaPass | $548K | 30 Dec 2018 | United Kingdom, England | ||
Lightpoint Medical | $6M | 06 Dec 2018 | United Kingdom, England, United Kingdom | ||
Molecular Warehouse | $1M | 08 Apr 2018 | United Kingdom, England, United Kingdom | ||
Sensize Ltd | $657K | 06 Apr 2018 | Cambridge, Cambridgeshire, United Kingdom | ||
Camnutra Ltd | $2M | 06 Dec 2017 | Cambridge, Massachusetts, United States | ||
SupaPass | $1M | 14 Jul 2017 | England | ||
Peptinnovate | $3M | 17 Jun 2017 | United Kingdom, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Liopa | $589K | 08 Apr 2019 | Belfast, Northern Ireland, United Kingdom | ||
SupaPass | $548K | 30 Dec 2018 | United Kingdom, England | ||
Lightpoint Medical | $6M | 06 Dec 2018 | United Kingdom, England, United Kingdom | ||
Molecular Warehouse | $1M | 08 Apr 2018 | United Kingdom, England, United Kingdom | ||
Sensize Ltd | $657K | 06 Apr 2018 | Cambridge, Cambridgeshire, United Kingdom | ||
Camnutra Ltd | $2M | 06 Dec 2017 | Cambridge, Massachusetts, United States | ||
SupaPass | $1M | 14 Jul 2017 | England | ||
Peptinnovate | $3M | 17 Jun 2017 | United Kingdom, England, United Kingdom |
